This study focuses on the severe side effects of BRAF and MEK inhibitors, specifically colitis, in patients with metastatic melanoma, as it's a standard treatment for V600E/K BRAF mutant cases.
Researchers analyzed 10 patients hospitalized for colitis after using these drugs, noting common symptoms like diarrhea and abdominal pain, along with severe medical complications, including ulcerations in the right colon.
The findings indicate that these medications can lead to serious gastrointestinal issues, with a significant number of patients having to discontinue treatment or requiring surgery, highlighting the need for careful monitoring.